Dana Maniu

Dr. Dana Maniu

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SSSorina Suarasan
Sorina Suarasan
Monica FocsanMonica Focsan
Monica Focsan
OSOlga Soritau
Olga Soritau
DMDana Maniu
Dana Maniu
SASimion Astilean
Simion Astilean

17 November 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
Andreea CampuAndreea Campu
Andreea Campu
IMIlinca Muresan
Ilinca Muresan
MPMonica Potara
Monica Potara
DLDiana Raluca Lazar
Diana Raluca Lazar
Florin Leontin LazarFlorin Leontin Lazar
Florin Leontin Lazar
Monica FocsanMonica Focsan
Monica Focsan
Portable microfluidic gold nanobipyramid-based biosensor for efficient, fast, real-time, on-site cardiac troponin I biomarker thermoplasmonic detection.

Tudor Lucian PopTudor Lucian Pop
Tudor Lucian Pop
DMDana Maniu
Dana Maniu
DRDaniela Rajka
Daniela Rajka
CLCecilia Lazea
Cecilia Lazea
Gabriel CismaruGabriel Cismaru
Gabriel Cismaru
SCsimona Cainap
simona Cainap
Introduction: During the last three decades, there has been an excess weight epidemic due to changes in nutrition and lifestyle. Few data on the prevalence of overweight and obesity in children in Romania were published, without a single study representative at the national level. There are reports on the higher level of overweight and obesity in urban areas compared to rural ones. This study aimed to estimate the prevalence of underweight, overweight, obesity and severe obesity in children enrolled in schools from the urban area. Material and methods: For this cross-sectional study, children from 177 schools from the urban area of five counties from the northwestern part of Romania were included after the parents signed written informed consent. Anthropometric data were recorded (weight, height) based on World Health Organization (WHO) recommendations and Body-Mass-Index (BMI), and the z-score for BMI were calculated. The nutritional status was estimated using three reference criteria: WHO, International Obesity Task Force (IOTC) and the Center for Disease Control and Prevention (CDC). Results: We analyzed data of 21,650 children (48.19% boys) age between 7 and 18 years. The prevalence of overweight was 13.8%, 16.2% and 20.3%, of obesity was 10.7%, 10.0% and 5.7% and of severe obesity was 5.1%, 1.2% and 1.6% (using WHO, CDC and IOTF cut-offs). Underweight was present in 5.2% (WHO), 6% (CDC) and 2.6% (IOTF). The highest prevalence of overweight (including obesity) was found in children aged 10 years, and the lowest in adolescents at 18 years. Boys have a higher prevalence of excess weight than girls. Using IOTF cut-offs, the prevalence of obesity and severe obesity was lower than using WHO criteria. Conclusions: The prevalence of overweight (including obesity) in children from the urban area of Western Romania was recorded at alarming levels, higher in boys and at the pre-puberty ages. There are significant differences based on the reference system used. It is important to correctly choose the reference for the definition of overweight and obesity to have the correct estimation of the target for public health measures.

2 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
RBRaluca Andra Borlan
Raluca Andra Borlan
DSDaria Stoia
Daria Stoia
LGLuiza Ioana Gaina
Luiza Ioana Gaina
Andreea CampuAndreea Campu
Andreea Campu
GMGabriel Marc
Gabriel Marc
SASimion Astilean
Simion Astilean
In recent times, researchers have aimed for new strategies to combat cancer by the implementation of nanotechnologies in biomedical applications. This work focuses on developing protein-based nanoparticles loaded with a newly synthesized NIR emitting and absorbing phthalocyanine dye, with photodynamic and photothermal properties. More precisely, we synthesized highly reproducible bovine serum albumin-based nanoparticles (75% particle yield) through a two-step protocol and successfully encapsulated the NIR active photosensitizer agent, achieving a good loading efficiency of 91%. Making use of molecular docking simulations, we confirm that the NIR photosensitizer is well protected within the nanoparticles, docked in site I of the albumin molecule. Encouraging results were obtained for our nanoparticles towards biomedical use, thanks to their negatively charged surface (−13.6 ± 0.5 mV) and hydrodynamic diameter (25.06 ± 0.62 nm), favorable for benefitting from the enhanced permeability and retention effect; moreover, the MTT viability assay upholds the good biocompatibility of our NIR active nanoparticles. Finally, upon irradiation with an NIR 785 nm laser, the dual phototherapeutic effect of our NIR fluorescent nanoparticles was highlighted by their excellent light-to-heat conversion performance (photothermal conversion efficiency 20%) and good photothermal and size stability, supporting their further implementation as fluorescent therapeutic agents in biomedical applications.

9 February 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
DSDaria Stoia
Daria Stoia
Madalina NistorMadalina Nistor
Madalina Nistor
MSMaria Suciu
Maria Suciu
RBRaluca Andra Borlan
Raluca Andra Borlan
Andreea CampuAndreea Campu
Andreea Campu
Monica FocsanMonica Focsan
Monica Focsan

20 July 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
RBRaluca Borlan
Raluca Borlan
Monica FocsanMonica Focsan
Monica Focsan
MPMaria Perde-Schrepler
Maria Perde-Schrepler
OSOlga Soritau
Olga Soritau
Andreea CampuAndreea Campu
Andreea Campu
SASimion Astilean
Simion Astilean
Among women, ovarian cancer is the fifth most frequent type of cancer, and despite benefiting from current standard treatment plans, 90% of patients relapse in the subsequent 18 months and, eventually, perish. As a result, via embracing nanotechnological advancements in the field of medical science, researchers working in the areas of cancer therapy and imaging are looking for the next breakthrough treatment strategy to ensure lower cancer recurrence rates and improved outcomes for patients. Herein, we design a novel phototheranostic agent with optical features in the biological window of the electromagnetic spectrum via encapsulating a newly synthesized phthalocyanine dye within biocompatible protein nanoparticles, allowing the targeted fluorescence imaging and synergistic dual therapy of ovarian cancer. The nanosized agent displays great biocompatibility and enhanced aqueous biostability and photothermal activity, as well as high reactive-oxygen-species generation efficiency. To achieve the active targeting of the desired malignant tissue and suppress the rapid clearance of the photosensitive agent from the peritoneal cavity, the nanoparticles are biofunctionalized with an anti-folate receptor antibody. A2780 ovarian cancer cells are employed to confirm the improved targeting capabilities and the in vitro cytotoxic efficiency of the theranostic nanoparticles after exposure to a 660 nm LED lamp; upon measurement via MTT and flow cytometry assays, a significant 95% decrease in the total number of viable cells is seen. Additionally, the therapeutic performance of our newly designed nanoparticles was evaluated in vivo, via real-time thermal monitoring and histopathological assays, upon the irradiation of tumour-bearing mice with a 660 nm LED lamp (0.05 W cm−2). Foremost, separately from steady-state fluorescence imaging, we found that, via utilizing FLIM investigations, the differences in fluorescence lifetimes of antibody biofunctionalized and non-functionalized nanoparticles can be correlated to different intracellular localization and internalization pathways of the fluorescent agent, which is relevant for the development of a cutting-edge method for the detection of cancer cells that overexpress folate receptors at their surfaces.